Evercore ISI Group Maintains In-Line on Agilon Health, Lowers Price Target to $4
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group has maintained an 'In-Line' rating on Agilon Health but has lowered the price target from $7 to $4, indicating a less optimistic outlook.
October 08, 2024 | 4:53 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Evercore ISI Group has maintained an 'In-Line' rating on Agilon Health but has lowered the price target from $7 to $4, suggesting a less optimistic view on the stock's potential.
The lowering of the price target from $7 to $4 by Evercore ISI Group indicates a negative sentiment towards Agilon Health's future performance. This could lead to a short-term decline in the stock price as investors react to the revised target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100